0001104659-19-046855.txt : 20190821
0001104659-19-046855.hdr.sgml : 20190821
20190821212149
ACCESSION NUMBER: 0001104659-19-046855
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190819
FILED AS OF DATE: 20190821
DATE AS OF CHANGE: 20190821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lavino Francesco Maria
CENTRAL INDEX KEY: 0001711517
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 191044103
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
a4.xml
4
X0306
4
2019-08-19
0
0001641640
Nabriva Therapeutics plc
NBRV
0001711517
Lavino Francesco Maria
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
Chief Commercial Officer
Ordinary Shares
2019-08-19
4
M
0
11250
A
14969
D
Ordinary Shares
2019-08-21
4
F
0
3797
2.08
D
11172
D
Restricted Share Units
2019-08-19
4
M
0
11250
0
D
Ordinary Shares
11250
11250
D
The restricted share units convert into ordinary shares on a one-for-one basis upon vesting of the units.
On January 31, 2018, Nabriva Therapeutics plc (the "Issuer") granted the reporting person 22,500 restricted share units ("RSUs"). Fifty percent (50%) of the RSUs vested on August 19, 2019 upon certifcation by the board of directors of the Issuer of the receipt by the Issuer of approval of a new drug application by the U.S. Food and Drug Administration for lefamulin (the "Performance Condition"), and the remaining fifty percent (50%) of the RSUs will vest on the one (1) year anniversary of the Performance Condition.
/s/ Robert Crotty, by power of attorney
2019-08-21